Diabetes drug manufacturers unable to prove any real benefit to patients

Diabetes drug manufacturers unable to prove any real benefit to patients
(Natural News) Manufacturers of diabetes drugs could not prove any real additional benefit of sitagliptin to individuals with diabetes, according to a report by the Institute for Quality and Efficiency in Health Care (IQWiG). The IQWiG reevaluated the effects of the diabetes drug known as sitagliptin compared to the appropriate comparator therapies for diabetic people….
19
Like
Save

Comments

Write a comment

*